Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer
Yuanxin Yao(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital), James G. Herman(UPMC Hillman Cancer Center), Lirong Zhang(Shijiazhuang University), Aiai Gao(Chinese PLA General Hospital), Honghui Lv(Chinese PLA General Hospital), Qian Wang(Xi'an Honghui Hospital), Yuan Li(Qingdao University), Malcolm V. Brock(Johns Hopkins University), Meiying Zhang(Chinese PLA General Hospital), François Fuks(Institut Jules Bordet)
Cited by 11
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|909
Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
|Journal of Clinical Oncology|2008|805
The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase
|Nucleic Acids Research|2003|737